Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Jan 9;296(6615):89–92. doi: 10.1136/bmj.296.6615.89

Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

T Havelund, L S Laursen, E Skoubo-Kristensen, B N Andersen, S A Pedersen, K B Jensen, C Fenger, F Hanberg-Sørensen, K Lauritsen
PMCID: PMC2544700  PMID: 3122967

Abstract

One hundred and sixty two patients with endoscopically proved reflux oesophagitis stratified for severity, 66 with grade 1 disease (erythema and friability) and 96 with grade 2 or 3 disease (including erosions or ulcerations), were allocated at random to double blind treatment with omeprazole 40 mg in the morning or ranitidine 150 mg twice daily for up to 12 weeks. A patient could be evaluated sooner if symptomatic relief and endoscopically normal mucosa (grade 0) were noted after four to eight weeks' treatment. Patients treated with omeprazole responded significantly more rapidly than those treated with ranitidine (p<0.0001), cumulative healing rates at four, eight, and 12 weeks being 90%, 100%, and 100% respectively for those with grade 1 disease and 70%, 85%, and 91% respectively for those with grade 2 or 3 disease in the omeprazole group. Corresponding rates in the ranitidine group were 55%, 79%, and 88% (grade 1) and 26%, 44%, and 54% (grade 2 or 3). Relief of the major symptoms of heartburn, regurgitation, and dysphagia and improvements in the histological appearance of the mucosa occurred earlier and were again more pronounced during treatment with omeprazole than with ranitidine.

This observed superiority of omeprazole 40 mg in the morning over ranitidine 150 mg twice daily in the short term treatment of reflux oesophagitis was obtained without major clinical or biochemical side effects, but further research is needed into longer term use of omeprazole and the effects of the acid inhibition it induces.

Full text

PDF
89

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardhan K. D., Bianchi Porro G., Bose K., Daly M., Hinchliffe R. F., Jonsson E., Lazzaroni M., Naesdal J., Rikner L., Walan A. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol. 1986 Aug;8(4):408–413. doi: 10.1097/00004836-198608000-00005. [DOI] [PubMed] [Google Scholar]
  2. Clissold S. P., Campoli-Richards D. M. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs. 1986 Jul;32(1):15–47. doi: 10.2165/00003495-198632010-00002. [DOI] [PubMed] [Google Scholar]
  3. Johansson K. E., Boeryd B., Johansson K., Tibbling L. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986 Sep;21(7):769–778. doi: 10.3109/00365528609011116. [DOI] [PubMed] [Google Scholar]
  4. Karvonen A. L., Keyriläinen O., Uusitalo A., Salaspuro M., Tarpila S., Andrén K., Helander H. F. Effects of omeprazole in duodenal ulcer patients. Scand J Gastroenterol. 1986 May;21(4):449–454. doi: 10.3109/00365528609015161. [DOI] [PubMed] [Google Scholar]
  5. Klinkenberg-Knol E. C., Jansen J. M., Festen H. P., Meuwissen S. G., Lamers C. B. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet. 1987 Feb 14;1(8529):349–351. doi: 10.1016/s0140-6736(87)91726-0. [DOI] [PubMed] [Google Scholar]
  6. Koelz H. R., Birchler R., Bretholz A., Bron B., Capitaine Y., Delmore G., Fehr H. F., Fumagalli I., Gehrig J., Gonvers J. J. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology. 1986 Nov;91(5):1198–1205. doi: 10.1016/s0016-5085(86)80017-8. [DOI] [PubMed] [Google Scholar]
  7. Langman M. J. Antisecretory drugs and gastric cancer. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1850–1852. doi: 10.1136/bmj.290.6485.1850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lauritsen K., Rune S. J., Bytzer P., Kelbaek H., Jensen K. G., Rask-Madsen J., Bendtsen F., Linde J., Højlund M., Andersen H. H. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. N Engl J Med. 1985 Apr 11;312(15):958–961. doi: 10.1056/NEJM198504113121505. [DOI] [PubMed] [Google Scholar]
  9. Schaub N., Meyrick Thomas J., Misiewicz J. J., Lovell D., Trotman I. F. Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease. Hepatogastroenterology. 1986 Oct;33(5):208–213. [PubMed] [Google Scholar]
  10. Sonnenberg A., Lepsien G., Müller-Lissner S. A., Koelz H. R., Siewert J. R., Blum A. L. When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment. Dig Dis Sci. 1982 Apr;27(4):297–302. doi: 10.1007/BF01296747. [DOI] [PubMed] [Google Scholar]
  11. Wesdorp E., Bartelsman J., Pape K., Dekker W., Tytgat G. N. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology. 1978 May;74(5 Pt 1):821–824. [PubMed] [Google Scholar]
  12. Wesdorp I. C., Dekker W., Klinkenberg-Knol E. C. Treatment of reflux oesophagitis with ranitidine. Gut. 1983 Oct;24(10):921–924. doi: 10.1136/gut.24.10.921. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES